Bacteroides salyersiae

Bacteria
General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview

  • Bacteroides salyersiae is a Gram-negative, non-spore-forming, strictly anaerobic, non-motile, rod-shaped bacterium. It has been detected in at least 15 gut microbiome compilation studies or metastudies. The DNA G+C content is 42.0%. Bacteroides salyersiae is a common gut coloniser. (Song2004; Song2010Bergeys)



  • This organism has been recovered from human faeces and appendix. The risk classification (www.baua.de) for this organism is 2, i.e., risk of individual infection, but low risk of spread. It is an opportunistic pathogen. Is a known gut commensal.
    • GENERAL CHARACTERISTICS (Song2004); (Song2010Bergeys);
    Character Response
  • Substrates hydrolysed or digested:
  • aesculin; gelatin;
  • 💧
  • Bile tolerance:
  • Resistant to 20% bile
  • H+
  • Acid from carbohydrates usually produced:
  • arabinose; glucose; mannose; xylose; lactose; maltose; raffinose; sucrose; glycerol;
  • ±
  • Strain-dependent acid from carbs:
  • rhamnose; cellubiose; sorbitol;
  • Active enzymes:
  • Ala arylamidase; alkaline phosphatase; acid phosphatase; N-Ac β-glucosaminidase; α-galactosidase; β-galactosidase; α-glucosidase; β-glucosidase; glutamic acid decarboxylase; Glu-Glu arylamidase; Leu-Gly arylamidase;
    • SPECIAL FEATURES (Song2004); (Song2010Bergeys);
    Character Response
  • ✓
  • Metabolites produced:
  • formate (minor); acetate (major); propionate (minor); valerate (minor); indole;
  • ✗
  • Nitrate:
  • not reduced
    • RESPONSE TO ANTIBIOTICS (Song2004); (Song2010Bergeys); (Goldstein2013b);
    Class Active Resistant
  • Penicillins:
  • amoxicillin-clavulanic acid; ertapenem; imipenem; meropenem; piperacillin-tazobactam;
  • penicillin G;
  • Cephalosporins:
  • cefotetan; ceftazidime; ceftizoxime;
  • Aminoglycosides:
  • kanamycin;
  • Heterocycles:
  • metronidazole;
  • Vancomycins:
  • vancomycin;
  • Miscellaneous antibiotics:
  • colistin;

  • Song, Y. L., Liu, C. X., McTeague, M., & Finegold, S. M. (2004). “Bacteroides nordii” sp. nov. and “Bacteroides salyersae” sp. nov. isolated from clinical specimens of human intestinal origin. Journal of Clinical Microbiology, 42(12), 5565–5570.

    • Details

    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Bacteroidetes Class:  Bacteroidia Order:  Bacteroidales Family:  Bacteroidaceae Genus:  Bacteroides Gram stain:  neg O2 Relation.:  strictly anaerobic Spore:  No spore Motility:  Sessile Morphology:  Rod
    Health:  Unknown
    Source:  human faeces and appendix
    DNA G+C(%):  42.0
    Bile reaction(%):  20(+)
    		Aesculin:  + Urea:  neg Gelatin:  +
    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    Arabinose:  + Glucose:  + Mannose:  + Rhamnose:  d Xylose:  + Cellubiose:  d Lactose:  + Maltose:  + Melezitose:  neg Sucrose:  + Trehalose:  neg Xylan:  neg Glycerol:  + Mannitol:  neg Sorbitol:  d Salicin:  neg
    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Catalase:  neg Urease:  neg α-Arab:  neg Ac-β-glcamnd:  + α-Fucosidase:  neg α-Galactosidase:  + β-Galactosidase:  + α-Glucosidase:  + β-Glucosidase:  + β-Glucuronidase:  vr ArgDH:  vr Chymotrypsin:  neg GluDC:  + AlanineAA:  + ArgAA:  neg GluGluAA:  + GlyAA:  vr LeuAA:  neg LeuGlyAA:  + PyrrolidAA:  neg AlkalineP:  + AcidP:  + Lipase:  neg
    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    Acetate, Succinate

    		Formate:  minor(+) Acetate:  Major(+) Propionate:  minor(+) Valerate:  minor(+) Indole:  +
    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    Augmentin:  S(≤8)
    amp-sulb:  Var(MIC50): 4, MIC90: 16, RNG: (1–32)
    penicillin_G:  R(≥32)
    piper-taz:  S(MIC50): 2, MIC90: 8, RNG: (0.06–16)
    ertapenem:  S(≤1)
    imipenem:  S(≤2)
    meropenem:  S(MIC50): 0.5, MIC90: 1, RNG: (0.125–32)
    cefotetan:  R(≥64)
    cefoxitin:  Var(MIC50): 16, MIC90: 64, RNG: (4–64)
    ceftazidime:  R(MIC50): >128, MIC90: >128, RNG: (16–>128)
    ceftizoxime:  R(≥32)
    kanamycin:  R(1000; disc)
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    tigecycline:  Var(MIC50): 0.5, MIC90: 8, RNG: (0.125–32)
    vancomycin:  R(≥128)
    metronidazole:  S(MIC50): 2, MIC90: 2, RNG: (0.5–2)
    clindamycin:  Var(MIC50): 2, MIC90: >128, RNG: (0.06–>128)
    colistin:  R(10; disc)

    References

    SPECIFIC REFERENCES FOR BACTEROIDES SALYERSIAE
  • Song2004 - Bacteroides nordii' sp. nov. and 'Bacteroides salyersae' sp. nov. Isolated from Clinical Specimens of Human Intestinal Origin.
  • Wexler2007 - Bacteroides : the Good, the Bad, and the Nitty-Gritty.
  • Song2010Bergeys - Bacteroides. In Bergey's manual of systematic bacteriology: Vol. 4. The Bacteroidetes, Spirochaetes, Tenericutes (Mollicutes), Acidobacteria, Fibrobacteres, Fusobacteria, Dictyoglomi, Gemmatimonadetes, Lentisphaerae, Verrucomicrobia, Chlamydiae, and Planctomycetes
  • Kim2018 - Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure
  • MayaLucas2019 - The gut microbiome of Mexican children affected by obesity
  • Goldstein2013b - Comparative in vitro activities of GSK2251052, a novel boron-containing leucyl-tRNA synthetase inhibitor, against 916 anaerobic organisms.
  • ...............................
    • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR BACTEROIDES SALYERSIAE
  • Browne2016 - Culturing of 'unculturable' human microbiota reveals novel taxa and extensive sporulation.
  • Byrd2020 - Stability and dynamics of the human gut microbiome and its association with systemic immune traits.
  • Chen2020 - Structural and Functional Characterization of the Gut Microbiota in Elderly Women With Migraine
  • Chen2020a - Featured Gut Microbiomes Associated With the Progression of Chronic Hepatitis B Disease
  • Forster2019 - A human gut bacterial genome and culture collection for improved metagenomic analyses.
  • Hu2019 - The Gut Microbiome Signatures Discriminate Healthy From Pulmonary Tuberculosis Patients
  • Jeong2021 - The effect of taxonomic classification by full-length 16S rRNA sequencing with a synthetic long-read technology
  • Lagier2016 - Culture of previously uncultured members of the human gut microbiota by culturomics.
  • Minerbi2019 - Altered microbiome composition in individuals with fibromyalgia
  • RajilicStojanovic2014 - The first 1000 cultured species of the human gastrointestinal microbiota.
  • Rothschild2018 - Environment dominates over host genetics in shaping human gut microbiota.
  • Urban2020 - Altered Fecal Microbiome Years after Traumatic Brain Injury
  • Yang2020 - Species-Level Analysis of Human Gut Microbiota With Metataxonomics.
  • Yang2020a - Establishing high-accuracy biomarkers for colorectal cancer by comparing fecal microbiomes in patients with healthy families
  • Zou2019 - 1,520 reference genomes from cultivated human gut bacteria enable functional microbiome analyses.
  • Zupancic2012 - Analysis of the Gut Microbiota in the Old Order Amish and Its Relation to the Metabolic Syndrome.
  • ...............................
    • GENERAL REFERENCES FOR BACTEROIDES SALYERSIAE
  • CCUG - Culture Collection University of Gothenburg - Entire Collection
  • Song2010Bergeys - Bacteroides. In Bergey's manual of systematic bacteriology: Vol. 4. The Bacteroidetes, Spirochaetes, Tenericutes (Mollicutes), Acidobacteria, Fibrobacteres, Fusobacteria, Dictyoglomi, Gemmatimonadetes, Lentisphaerae, Verrucomicrobia, Chlamydiae, and Planctomycetes
    • Added: April 08, 2021